Virtual Reality and Outpatient Hysteroscopy
Launched by IMPERIAL COLLEGE LONDON · Oct 4, 2018
Trial Information
Current as of June 20, 2025
Completed
Keywords
ClinConnect Summary
INTRODUCTION
BACKGROUND Performing procedures for investigation and treatment of gynaecological conditions in the office setting is becoming commonplace. Outpatient gynaecological procedures can reduce risks of general anaesthetic, decrease health care costs and make the procedure more convenient for the patient and provider. However, ensuring adequate pain relief and allaying anxiety during the procedure can prove to be challenging. Appropriate patient selection, counselling and adequate pain management during the procedure can improve patient experience and reduce the number of failed pr...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients: Inclusion criteria will include all women of at least 18 - 70 years of age, planned for an office hysteroscopy.
- • Staff: Inclusion criteria will include the clinician performing the outpatient hysteroscopy and the nurse supporting the clinic.
- Exclusion Criteria:
- Patients:
- • Hearing impairments and blindness
- • Any known anatomical characteristics that may make performing the office procedure more difficult (e.g., cervical conization, Manchester Fothergill).
- • The denial or withdrawal of oral informed consent Staff: The denial or withdrawal of informed consent
About Imperial College London
Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Nandita Deo, FRCOG
Principal Investigator
Imperial College London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials